Jose L. Luque-Garcia

Assistant Professor

Universidad Complutense de Madrid

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Cancer Biology Cancer Biology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jose L. Luque-Garcia is an Assistant Professor at Universidad Complutense de Madrid, Spain. His research primarily focuses on the mechanisms of cancer treatment, including the antitumor effects of nanoparticles and the role of SUMOylation in breast cancer. Recent publications highlight the use of multi-omics approaches to explore cellular responses and therapeutic strategies in various cancer models.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Luisa María Villar

Universidad de Alcalá

SPAIN

View details

Blanca González

Associate Professor

Universidad Complutense de Madrid

SPAIN

View details

Rafael Prados-Rosales

Universidad Autónoma de Madrid

SPAIN

View details

Manuel Comabella

SPAIN

View details

Estefanía García Calvo

Universidad Complutense de Madrid

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jose L. Luque-Garcia

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Short‐chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile

SILAC-based nuclear proteomics uncovers antitumor mechanisms of selenium nanoparticles with in vivo validation in a melanoma model

SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts

Maintenance of cell wall remodeling and vesicle production are connected in Mycobacterium tuberculosis

Mechanistic insights into the antitumoral potential and in vivo antiproliferative efficacy of a silver-based core@shell nanosystem

Advancing rhodium nanoparticle-based photodynamic cancer therapy: quantitative proteomics and in vivo assessment reveal mechanisms targeting tumor metabolism, progression and drug resistance

Integrated transcriptomics and metabolomics analysis reveals the biomolecular mechanisms associated to the antitumoral potential of a novel silver-based core@shell nanosystem

Unraveling the Mechanisms of Ch-SeNP Cytotoxicity against Cancer Cells: Insights from Targeted and Untargeted Metabolomics

Dual delivery of antigens shows promise

A Multi-Omics Approach to Evaluate the Toxicity Mechanisms Associated with Silver Nanoparticles Exposure

A novel hemocompatible core@shell nanosystem for selective targeting and apoptosis induction in cancer cells

Integration of untargeted and targeted mass spectrometry-based metabolomics provides novel insights into the potential toxicity associated to surfynol

Rhodium Nanoparticles as a Novel Photosensitizing Agent in Photodynamic Therapy against Cancer

Collaborators (5)

Luisa María Villar

Blanca González

Rafael Prados-Rosales

Manuel Comabella

Estefanía García Calvo

Make your next move.